[Identification and prevention of vascular risk. Significance of metformin].
Isnard
F
F
Département de Recherche Clinique des Laboratories Aron-Medicia, Groupe LIPHA, Suresnes.
André
P
P
D000886:Anthropometry; D003327:Coronary Disease / Q000209:etiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology; D003925:Diabetic Angiopathies / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications* / Q000378:metabolism; D012307:Risk Factors; D013577:Syndrome
D008687:Metformin
Identification et prévention du risque vasculaire. Intérêt de la metformine.